Skip to main content
. 2021 Jul 2;5:63. doi: 10.1038/s41698-021-00202-2

Fig. 5. Circulating tumor fraction estimate (cfTE) and abstracted clinical outcomes in a sub-cohort of the xF 1000 (n = 388).

Fig. 5

a Patients with complete response (n = 9, ctFE = 0.05) exhibited lower ctFEs than those with progressive disease (n = 298, ctFE = 0.08), partial response (n = 56, ctFE = 0.06), or stable disease (n = 25, ctFE = 0.06). b ctFE was also assessed temporally among a few randomly selected patients with multiple xF tests throughout the course of treatment (n = 26), with most patients showing large differences in ctFEs between test dates.